These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
635 related items for PubMed ID: 16004809
1. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation]. Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS. Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809 [Abstract] [Full Text] [Related]
3. [Comparision of different interventional therapies for primary liver cancer]. Liu YM, Qin H, Wang CB, Fang XH, Ma QY. Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):232-5. PubMed ID: 17649645 [Abstract] [Full Text] [Related]
4. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Yang P, Liang M, Zhang Y, Shen B. Adv Ther; 2008 Aug; 25(8):787-94. PubMed ID: 18670743 [Abstract] [Full Text] [Related]
6. [Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma]. Li ZR, Kang Z, Qian JS, Zhu KS, Jiang ZB, Huang MS, Guan SH, Shan H. Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1749-51. PubMed ID: 18024306 [Abstract] [Full Text] [Related]
7. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, Kudryk B, Zwiebel B, Black T, Fargher S, Rosemurgy AS. Am Surg; 2002 Sep; 68(9):827-31. PubMed ID: 12356160 [Abstract] [Full Text] [Related]
8. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study. Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T. J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115 [Abstract] [Full Text] [Related]
11. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma]. Chen XM, Luo PF, Lin HH, Zhou ZJ, Shao PJ, Fu L, Li WK. Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922 [Abstract] [Full Text] [Related]
14. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients. Huang ZM, Li W, Li S, Gao F, Zhou QM, Wu FM, He N, Pan CC, Xia JC, Wu PH, Zhao M. J Immunother; 2013 Jun; 36(5):287-93. PubMed ID: 23719239 [Abstract] [Full Text] [Related]
15. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L. Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905 [Abstract] [Full Text] [Related]
16. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial]. Zhao M, Wu PH, Zeng YX, Xia JC, Zhang FJ, Xian LJ, Zhang YP, Zhou K, Fan WJ, Zhang L, Gao F, Zhou QM. Zhonghua Yi Xue Za Zhi; 2006 Jul 11; 86(26):1823-8. PubMed ID: 17054858 [Abstract] [Full Text] [Related]
19. Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment. Toro A, Pulvirenti E, Palermo F, Di Carlo I. Surg Oncol; 2012 Mar 11; 21(1):e23-30. PubMed ID: 22104002 [Abstract] [Full Text] [Related]